Shionogi Archives -

A Japanese language version of Akili Interactive’s EndeavorRx ground-breaking digital therapy for attention deficit hyperactivity disorder (ADHD) has

Shionogi starts pivotal Japanese trial of Akili’s ADHD app

https://pharmaphorum.com/news/shionogi-starts-pivotal-japanese-trial-of-akilis-adhd-app/

News/ News/ Sales and Marketing

UK launches its ‘Netflix-style’ payment model for antibiotics

Phil Taylor antibiotic, antimicrobial resistance, Fetcroja, NHS, NICE, Pfizer, Shionogi, UK, value-based models, Zavicefta 0 Comment

The UK is poised to become the first country in the world to launch a new payment model

UK launches its ‘Netflix-style’ payment model for antibiotics

https://pharmaphorum.com/news/uk-launches-its-netflix-style-payment-model-for-antibiotics/

News/ News/ Sales and Marketing

Tivicay approved in Europe in new dispersible tablet for children with HIV

Richard Staines GlaxoSmithKline, HIV, infectious diseases, Pfizer, Shionogi, Tivicay 0 Comment

ViiV’s Tivicay is to become available in Europe in a new dispersible tablet form to treat children living

Tivicay approved in Europe in new dispersible tablet for children with HIV

https://pharmaphorum.com/news/tivicay-approved-in-europe-in-new-dispersible-tablet-for-children-with-hiv/

News/ News/ R&D/ Top stories

Shionogi and Tetra expand partnership ahead of Alzheimer’s trial readout

Richard Staines Alzheimer's, Biogen, Fragile X Syndrome, neurology, Shionogi, Tetra 0 Comment

Shionogi has expanded its partnership with its Alzheimer’s drug development partner Tetra Therapeutics, giving an option for a

Shionogi and Tetra expand partnership ahead of Alzheimer’s trial readout

https://pharmaphorum.com/news/shionogi-and-tetra-expand-partnership-ahead-of-alzheimers-trial-readout/

Market Access/ News/ News

Boehringer bags CHMP backing for Ofev in rare lung disease

Phil Taylor Accord Healthcare, Boehringer Ingelheim, Celgene, CHMP, PharmaMar, Shionogi, Takeda 0 Comment

Boehringer Ingelheim has moved a step closer to getting approval for its blockbuster respiratory drug Ofev as the

Boehringer bags CHMP backing for Ofev in rare lung disease

https://pharmaphorum.com/news/boehringer-bags-chmp-backing-for-ofev-in-rare-lung-disease/

Market Access/ News/ News

UK’s NHS to fund Shionogi’s Mulpleo after backing from NICE and SMC

Richard Staines cost-effectiveness, market access, NICE, Shionogi 0 Comment

Shionogi’s Mulpleo for severely low levels of blood platelets caused by liver disease is to be made available

UK’s NHS to fund Shionogi’s Mulpleo after backing from NICE and SMC

https://pharmaphorum.com/news/uks-nhs-to-fund-shionogis-mulpleo-after-backing-from-nice-and-smc/

News/ News/ R&D

Roche’s Tamiflu successor on target in phase 3 trial

Richard Staines infectious diseases, Roche, Shionogi 0 Comment

A trial of Roche’s successor to flu medicine Tamiflu has met its goal in a phase 3 trial,

Roche’s Tamiflu successor on target in phase 3 trial

https://pharmaphorum.com/news/roches-tamiflu-successor-on-target-in-phase-3-trial/

News

ViiV’s Dovato HIV pill approved in EU

Richard Staines GlaxoSmithKline, HIV, infectious diseases, Pfizer, Shionogi, ViiV 0 Comment

ViiV’s new daily HIV treatment has been approved in the EU, as the company aims to win over

ViiV’s Dovato HIV pill approved in EU

https://pharmaphorum.com/news/viivs-dovato-hiv-pill-approved-in-eu/

Market Access/ News/ News

Sandoz to commercialise opioid induced constipation tablet in EU

George Underwood opioid, Rizmoic, Sandoz, Shionogi 0 Comment

As it continues to look into drugs that can help opioid-dependant patients, Sandoz has signed an agreement with Shionogi

Sandoz to commercialise opioid induced constipation tablet in EU

https://pharmaphorum.com/news/sandoz-to-commercialise-opioid-induced-constipation-tablet-in-eu/

Trending

Shionogi

Login